Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study
Jan Tack(KU Leuven), M. Scott Harris(Altimmune (United States)), Philip B. Miner(Oklahoma Foundation for Digestive Research), L. Fischer(Ocera Therapeutics (United States))
Cited by 40
Related Papers
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
|Gastroenterology|2020|2.1k
Pneumatic Dilation versus Laparoscopic Heller's Myotomy for Idiopathic Achalasia
|New England Journal of Medicine|2011|852
Development and Validation of the Rome IV Diagnostic Questionnaire for Adults
|Gastroenterology|2016|696